Immediate Impact

3 from Science/Nature 69 standout
Sub-graph 1 of 21

Citing Papers

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
2023 Standout
2 intermediate papers

Works of Alessandro Suppini being referenced

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach
2007

Author Peers

Author Last Decade Papers Cites
Alessandro Suppini 173 238 173 11 427
Erin McCarthy 57 140 86 14 376
Benedetta Marigliano 117 99 54 21 449
Ivana A. Vaughn 72 135 50 14 415
Maria Turchese Caletti 121 177 179 18 428
Luca Montesi 163 90 134 12 484
Rachel Pryke 169 179 148 11 474
Denis Foschini 194 131 63 21 470
Tun-Jen Hsiao 99 95 47 15 447
Ann Scheimann 87 128 68 19 395
Jidong Sung 123 100 52 10 424

All Works

Loading papers...

Rankless by CCL
2026